1,701
Views
0
CrossRef citations to date
0
Altmetric
Study Design Article

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh

ORCID Icon, , , , , , ORCID Icon, , , , , & show all
Article: 1574544 | Received 17 Sep 2018, Accepted 17 Jan 2019, Published online: 15 Feb 2019

References

  • Cavailler P, Lucas M, Perroud V, et al. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine. 2006;24:4890–9.
  • Thiem, V.D., Hossain M.M., Son N.D., et al. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr. 2003;304–308.
  • Legros D, Paquet C, Perea W, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77:837–842.
  • Clemens J, Harris J, Khan MR, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet. 1986;328:124–127.
  • Lucas MES, Deen JL, von Seidlein L, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med. 2005;352:757–767.
  • Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011;5:e1289.
  • Kar SK, Sah B, Patnaik B, et al. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. PLoS Negl Trop Dis. 2014;8:e2629.
  • Ciglenecki I, Sakoba K, Luquero FJ, et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med. 2013;10:e1001512.
  • Khan IA, Saha A, Chowdhury F, et al. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine. 2013;31:6058–6064.
  • Longini IM Jr, Nizam A, Ali M, et al. Controlling endemic cholera with oral vaccines. PLoS Med. 2007;4:e336.
  • WHO. Cholera vaccines: WHO position paper. WHO Weekly Epidemiological Rec. 2010;85:117–118.
  • World Health Organization. Meeting of the strategic advisory group of experts on immunization, October 2009-conclusions and recommendations. Weekly Epidemiological Rec. 2009;84:517–532.
  • Cholera Annual Report. WHO. weekly epidemiological record. World Health Organ. 2007;82:273-284.
  • Abubakar A, Azman AS, Rumunu J, et al. The first use of the global oral cholera vaccine emergency stockpile: lessons from South Sudan. PLoS medicine. 2015;12.11 (2015): e1001901.
  • SN, Pezzoli L, Martin S, Costa A, Rodriguez C, Legros D, et al. A second affordable oral cholera vaccine: implications for the global vaccine stockpile. Lancet Glob Health. 2016 Apr;4(4):e223–4. DOI:10.1016/S2214-109X(16)00037-1
  • Desai SN, Pezzoli L, Alberti KP, Martin S, Costa A, Perea W, et al. Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era. Hum Vaccin Immunother. 2016. Nov 4;1:0. DOI:10.1080/21645515.2016.1245250
  • WHO Cholera Fact sheet No 107. Cited 2018 October 1. Available at: http://www.who.int/mediacentre/fact-sheets/fs107/en/
  • David A, Sack RBS, Nair GB, et al. Cholera. Lancet. 2004;363:223–233.
  • Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477(7365):462.
  • Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012;379:2466–2476.
  • Samadi A, Chowdhury MK, Huq MI, et al. Seasonality of classical and El Tor cholera in Dhaka, Bangladesh: 17-year trends. Trans R Soc Trop Med Hyg. 1983;77:853–856.
  • Siddique, A., Aman K., Baqui A.H., et al. Cholera epidemics in Bangladesh: 1985–1991. J Diarrhoeal Dis Res. 1992;79–86.
  • Longini IM, Yunus M, Zaman K, et al. Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J Infect Dis. 2002;186:246–251.
  • Sack RB, Siddique AK, Longini IM, et al. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis. 2003;187:96–101.
  • Chowdhury F, Rahman MA, Begum YA, et al. Impact of rapid urbanization on the rates of infection by vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2011;5:e999.
  • Glass RI, Becker S, Huq MI, et al. Endemic cholera in rural Bangladesh, 1966–1980. Am J Epidemiol. 1982;116:959–970.
  • Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015;386:1362–1371.
  • Uddin MJ, Wahed T, Saha NC, et al. Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh. Vaccine. 2014;32:5690–5695.
  • Sarker AR, Islam Z, Khan IA, et al. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh. Vaccine. 2015;33:4916–4921.
  • Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9:e0003832.
  • Islam MT, Clemens JD, Qadri F. Cholera control and prevention in Bangladesh: an evaluation of the situation and solutions. J Infect Dis. 2018;40:S1–S2.
  • Khan AI, Islam MT, Qadri F. Safety of oral cholera vaccines during pregnancy in developing countries. Hum Vaccin Immunother. 2017;13:2245–2246.
  • Saha A, Khan A, Salma U, et al. The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants. Vaccine. 2016;34:1551–1558.
  • UNICEF. Available from: http://www.unicef.org/bangladesh/media_6007.htm.